| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | -91.1% |
| R&D Expense | $34.5M | — | -3.6% |
| SG&A Expense | $15.1M | — | -11.3% |
| Operating Income | -$47.1M | — | -84.0% |
| Pre-tax Income | -$46.4M | — | -109.4% |
| Income Tax | -$2.2M | — | -541.7% |
| Net Income | -$44.2M | — | -95.1% |
| EPS (Basic) | -$0.59 | — | -96.7% |
| EPS (Diluted) | -$0.59 | — | -96.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $244.3M | +493.5% | +220.6% |
| Accounts Receivable | $4.7M | +0.8% | -81.0% |
| Current Assets | $385.7M | +55.0% | +25.8% |
| Total Assets | $478.2M | +38.0% | +12.4% |
| Current Liabilities | $35.6M | -15.8% | -45.2% |
| Total Liabilities | $314.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.7M | — | -1241.9% |
| Capital Expenditures | $216K | — | +1250.0% |
| Investing Cash Flow | $70.0M | — | +474.3% |
| Financing Cash Flow | $178.8M | — | — |
| Free Cash Flow | -$45.9M | — | -1241.9% |
| +212.9% |
| Stockholders' Equity | $163.6M | -39.1% | -49.7% |